Tech Company Financing Transactions

Atox Bio Funding Round

Arix Bioscience, Adams Street Partners and Asahi Kasei invested in a $30 million funding round for Atox Bio. This VC investment round was announced on 12/5/2017.

Transaction Overview

Company Name
Atox Bio
Announced On
12/5/2017
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors

Arix Bioscience (Lead Investor) (Jonathan Tobin)

Adams Street Partners (Terry Gould)

Asahi Kasei

Becker Ventures

Lundbeckfond Ventures

OrbiMed

SR One Capital Management (Matthew Foy)

Proceeds Purpose
Atox Bio will use the proceeds of the financing to advance the clinical development of Reltecimod, its lead product, into Acute Kidney Injury (AKI), a major unmet clinical need in critically ill patients with severe infections.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
55 Vilcom Ctr. Dr. 230
Chapel Hill, NC 27514
USA
Phone
(919) 636-7260
Website
www.atoxbio.com
Email Address
Not Recorded
Overview
Atox Bio is a clinical stage biotechnology company that develops therapeutics for diseases mediated by a deregulated inflammatory response.
Profile
Atox Bio LinkedIn Company Profile
Social Media
Atox Bio Company Twitter Account
Company News
Atox Bio News
Facebook
Atox Bio on Facebook
YouTube
Atox Bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Daniel Teleman
  Daniel Teleman LinkedIn Profile  Daniel Teleman Twitter Account  Daniel Teleman News  Daniel Teleman on Facebook
Chief Financial Officer
Esti Hayun
  Esti Hayun LinkedIn Profile  Esti Hayun Twitter Account  Esti Hayun News  Esti Hayun on Facebook
Chief Medical Officer
Wayne Dankner
  Wayne Dankner LinkedIn Profile  Wayne Dankner Twitter Account  Wayne Dankner News  Wayne Dankner on Facebook
Chief Scientific Officer
Raymond Kaempfer
  Raymond Kaempfer LinkedIn Profile  Raymond Kaempfer Twitter Account  Raymond Kaempfer News  Raymond Kaempfer on Facebook
Vice President
Corinne Zollmann
  Corinne Zollmann LinkedIn Profile  Corinne Zollmann Twitter Account  Corinne Zollmann News  Corinne Zollmann on Facebook
VP - Bus. Development
Robert Greif
  Robert Greif LinkedIn Profile  Robert Greif Twitter Account  Robert Greif News  Robert Greif on Facebook
VP - R & D
Anat Shirvan
  Anat Shirvan LinkedIn Profile  Anat Shirvan Twitter Account  Anat Shirvan News  Anat Shirvan on Facebook
VP - Regulatory Affairs
Meir Batito
  Meir Batito LinkedIn Profile  Meir Batito Twitter Account  Meir Batito News  Meir Batito on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/5/2017: Applied Data Finance venture capital transaction
Next: 12/5/2017: Elsen venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.